Scynexis (SCYX) Change in Inventory (2022 - 2023)
Scynexis' (SCYX) quarterly Change in Inventory came in at $1.5 million in Q4 2023, up 60.66% on a YoY basis from $910000.0 in Q4 2022, and down 48.23% quarter-over-quarter from $2.8 million in Q3 2023.
Powered by 
Analysis
Scynexis (SCYX) Change in Inventory (2022 - 2023) Analysis & Trends
Scynexis (SCYX) has reported Change in Inventory for 2 consecutive years, with $1.5 million the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Change in Inventory rose 60.66% year-over-year to $1.5 million; the trailing twelve-month figure through Sep 2024 stood at $1.5 million (down 82.38% YoY), and the FY2023 full-year result was $8.8 million, up 1929.59% from the prior year.
- Change in Inventory declined to $1.5 million in Q4 2023 per SCYX's latest filing, from $2.8 million in the prior quarter.
- Across five years, Change in Inventory topped out at $2.8 million in Q3 2023 and bottomed at -$797000.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 31.00 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 145.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 27.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 28.20 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 132.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -280,000.00 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -75.70 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Dec 31, 2022 | 910,000.00 |
| Sep 30, 2022 | -797,000.00 |